Contineum Therapeutics Inc. (CTNM) PE Ratio

Contineum Therapeutics Inc. (CTNM) PE ratio history, current valuation, and earnings analysis. Track price-to-earnings trends in Excel with MarketXLS.

PE Ratio Data

PeriodPE Ratio
2024-12-31-5.92

Get Contineum Therapeutics Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =PERatio("CTNM")

BUY NOW